首页行业分类生物医药生物2023-03-24-西南证券-智飞生物-代理品种维持增长,自主产品蓄势待发
PDF

2023-03-24-西南证券-智飞生物-代理品种维持增长,自主产品蓄势待发

迟***94页1.14M

下载文档
/4
全屏查看
2023-03-24-西南证券-智飞生物-代理品种维持增长,自主产品蓄势待发
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
智飞生物(300122)2022年年报点评2022A2023E2024E2025E2022A2023E2024E2025E38264.0150002.1058224.7960909.147539.009424.0710756.9510934.70营业成本25395.5033301.4038835.9440626.39折旧与摊销320.76440.25478.65517.51营业税金及册加177.02228.14265.43278.4413.80170.80222.04288.65销售货用2235.243550.154075.744263.64-108.87400.00500.00500.00374.13750.03873.37913.64经营营运黄本变动-8550.82511.98-215.00-1301.12财务货用13.80170.80222.04288.65其他2775.16310.66-317.82-429.63-108.87400.00500.00500.001989.039612.4811424.8210510.120.000.000.000.00-1553.52-500.00-500.00-500.000.000.000.000.0055.570.000.000.00其他经营损益0.0015.0020.0025.00-1497.95500.00-500.00-500.008758.3811137.1412705.1712912.72短期借款1216.06.1784.920.000.00-40.37-49.99-49.94-48.36-25.770.000.000.008718.0111087.1412655.2312864.360.000.000.000.00所得税1179.011663.071898.281929.65支付股利-960.00-708.96-886.23-1011.577539.009424.0710756.9510934.70-2402.93-180.61-222.04-288.650.000.000.000.00-2172.65-2674.48-1108.27-1300.227539.009424.0710756.9510934.70.1664.016438.009816.558709.892022A2023E2024E2025E2022A2023E2024E2025E2622.069060.0718876.6227586.51成长能力应收和预付款项20725.4324345.3028812.1930467.4024.83%30.68%16.44%4.61%存货8020.4710498.8912248.2412818.38-27.01%27.16%14.08%1.63%其他流动黄产45.3959.3269.0872.26-26.15%25.00%14.14%1.65%0.000.000.000.00BTDA增长率-26.71%29.20%14.11%2.33%10.1510.1510.1510.154653.844776.664861.084906.64毛利率33.63%33.40%33.30%33.30%无彩资产和开发支出1075.731015.48955.23894.996.86%8.94%8.88%8.97%850.66847.84845.01842.1919.70%18.85%18.47%17.95%38003.7350613.7066677.6077598.52ROE31.11%28.60%25.12%20.73%1784.920.000.000.00ROA19.84%18.62%16.13%14.09%11151.0716752.1622883.4123861.15ROIC35.34%35.02%38.27%37.54%长期借款210.64210.64210.64210.6423.76%23.50%23.02%22.52%620.90699.57761.51781.5513767.5217662.3723855.5624853.341.121.130.990.84股本1600.001600.001600.001600.0016.8717.6720.5121.66207.96207.96207.96207.962.202.152.131.9922428.2531143.3641014.0850937.21存货周转率3.283.593.413.2324236.2132951.3342822.0452745.1881.51%0.000.000.000.0024236.2132951.3342822.0452745.1836.23%34.90%35.78%32.03%38003.7350613.7066677.6077598.52带息债务感负债14.49%1.19%0.88%0.85%流动比率2.372.572.572.922022A2023E2024E2025E速动比率1.771.952.052.39EBITDA9092.9411748.1913405.8613718.88股利支付率12.73%7.52%8.24%9.25%E18.5714.8613.0212.805.784.253.272.654.715.896.726.83PS3.662.802.402.3015.1520.5926.7632.97EV/EBITDA15.2411.098.998.15每股经营现金1.246.017.146.570.69%0.51%0.63%0.72%每股股利0.600.440.550.63请务必阅读正文后的重要声明部分